EL vs NKTR · rev $15.05B vs rev $21.0M
Estee Lauder Companies Inc (EL) versus Nektar Therapeutics (NKTR) — a side-by-side from cached financials, not a winner call.
Estee Lauder Companies Inc (EL) is a household & personal products company listed on US.
Nektar Therapeutics (NKTR) is a biotechnology company listed on US.
Latest reported EL revenue for 2026-06-30 was $15.05B. Net income was $182.0M. Revenue was up 5.0% from 2025-06-30 to 2026-06-30. EL currently screens at market cap $31.92B.
Latest reported NKTR revenue for 2026-06-30 was $21.0M. Net income was -$85.5M. Revenue was up 93.3% from 2026-03-31 to 2026-06-30. NKTR currently screens at market cap $307.2M.
EL currently screens at market cap $31.92B. NKTR currently screens at market cap $307.2M.
Not investment advice. Open the EL and NKTR stock pages for the full models.
Not investment advice.